Recombinant Human HBEGF Protein，His

HB-EGF (Heparin-binding EGF-like growth factor) is a member of the epidermal growth factor (EGF) family and plays a crucial role in various physiological and pathological processes, including cell growth, differentiation, wound healing, and inflammation. Its unique structure allows it to interact with multiple receptors, notably the EGF receptor (EGFR) and the heparan sulfate proteoglycans, which enhances its biological activity. Research has indicated that HB-EGF is overexpressed in several cancers, making it a potential marker for tumor progression and a target for therapeutic interventions. Moreover, HB-EGF is involved in the regulation of cellular responses to stress and injury, suggesting its significance in tissue repair mechanisms. The recombinant production of HB-EGF has become a focal point in biotechnological studies, enabling detailed investigations into its functions and therapeutic applications. By utilizing recombinant DNA technology, researchers can produce HB-EGF in a controlled manner, facilitating studies on its role in promoting cell proliferation and survival, as well as its impact on various signaling pathways. This not only enhances our understanding of HB-EGF's biological functions but also paves the way for developing new strategies in cancer treatment and regenerative medicine. Overall, the study of recombinant HB-EGF is vital for elucidating its multifaceted roles in health and disease, and it holds promise for innovative therapeutic approaches in conditions where HB-EGF modulation could be beneficial.